Weekly issue 2026-W37 ·
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for Autosomal Dominant Polycystic Kidney Disease
Plain language
U.S. kidney experts (KDOQI) walk through the international KDIGO 2025 ADPKD guideline and what it means for everyday care in the United States — from diagnosis and imaging to treatment choices. Helpful when comparing global recommendations with what your local clinic can offer.
Clinical note
KDOQI society commentary on the KDIGO 2025 ADPKD clinical practice guideline (AJKD). Use as a U.S.-practice bridge to the parent KDIGO CPG (diagnosis, risk stratification, disease-modifying therapy, extra-renal care). Not primary evidence — verify local formulary, imaging access, and payer constraints before changing pathways.
Question for your next visit
Which parts of the international ADPKD care recommendations apply to me, given the tests and treatments available here?